Literature DB >> 28687104

Angiotensin-converting Enzyme Inhibitor and Other Drug-associated Angioedema.

Cosby Stone1, Nancy J Brown2.   

Abstract

Nonsteroidal antiinflammatory agents, β-lactam antibiotics, non-β lactam antibiotics, and angiotensin-converting enzyme inhibitors are the most common classes of drugs that cause angioedema. Drug-induced angioedema is known to occur via mechanisms mediated by histamine, bradykinin, or leukotriene, and an understanding of these mechanisms is crucial in guiding therapeutic decisions. Nonallergic angioedema occurs in patients with genetic variants that affect metabolism or synthesis of bradykinin, substance P, prostaglandins, or leukotrienes, or when patients are taking drugs that have synergistic mechanisms. The mainstay in treatment of nonallergic drug-induced angioedema is cessation of the offending agents.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ACE inhibitor; Angioedema; Bradykinin; Drug; Leukotriene; Medication; NSAID

Mesh:

Substances:

Year:  2017        PMID: 28687104     DOI: 10.1016/j.iac.2017.04.006

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  10 in total

Review 1.  Immune-mediated adverse reactions to vaccines.

Authors:  Cosby A Stone; Christine R F Rukasin; Thomas M Beachkofsky; Elizabeth J Phillips
Journal:  Br J Clin Pharmacol       Date:  2019-11-05       Impact factor: 4.335

2.  Enalapril-Induced Angioedema: Two Case Reports in a Rural Health Facility in Kenya.

Authors:  Mitchel Okumu; Francis Ochola; Calvin Bodo; Kevin Apuoyo; Nelson Odhiambo; Albert Ng'ong'a
Journal:  Cureus       Date:  2018-05-02

3.  A Forgotten Cause of Allergy at ER That Is Still Difficult to Diagnose and Treat at Poor Resource Setting: Angioedema after Using Angiotensin Converting Enzyme Inhibitors for 4 Years.

Authors:  A A Nilanga Nishad; K Arulmoly; S A S Priyankara; P K Abeysundara
Journal:  Case Reports Immunol       Date:  2019-01-02

Review 4.  Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.

Authors:  Lauren B Arendse; A H Jan Danser; Marko Poglitsch; Rhian M Touyz; John C Burnett; Catherine Llorens-Cortes; Mario R Ehlers; Edward D Sturrock
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

5.  Angioedema Caused by Drugs That Prevent the Degradation of Vasoactive Peptides: A Pharmacovigilance Database Study.

Authors:  Yoshihiro Noguchi; Azusa Murayama; Hiroki Esaki; Mayuko Sugioka; Aisa Koyama; Tomoya Tachi; Hitomi Teramachi
Journal:  J Clin Med       Date:  2021-11-25       Impact factor: 4.241

Review 6.  Angioedema associated with dipeptidyl peptidase-IV inhibitors.

Authors:  Nicoletta Cassano; Eustachio Nettis; Elisabetta Di Leo; Francesca Ambrogio; Gino A Vena; Caterina Foti
Journal:  Clin Mol Allergy       Date:  2021-12-06

7.  Pharmacovigilance study of the association between dipeptidyl peptidase-4 inhibitors and angioedema using the FDA Adverse Event Reporting System (FAERS).

Authors:  Katsuhiro Ohyama; Junichiro Shindo; Tomohiro Takahashi; Hironori Takeuchi; Yusuke Hori
Journal:  Sci Rep       Date:  2022-07-30       Impact factor: 4.996

8.  Fatal outcome of late-onset angiotensin-converting enzyme inhibitor induced angioedema: A case report.

Authors:  Jone Jackeviciute; Vidas Pilvinis; Rugile Pilviniene
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

9.  ACE-Inhibitor Related Angioedema Is Not Sufficiently Reported to the Danish Adverse Drug Reactions Database.

Authors:  Johan Emil Lundbek Cornwall; Anette Bygum; Eva Rye Rasmussen
Journal:  Drug Healthc Patient Saf       Date:  2019-12-16

10.  Angioedema in African American Patients Hospitalized for COVID-19.

Authors:  Einas Batarseh; Brian P Kersten; Anna C Pinelo; Jamie N Nadler; Stanley A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2020-12-01       Impact factor: 21.405

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.